Yes, mannitol is a hypertonic solution. The concentration used most often in clinical settings, 20% mannitol, has an osmolality of roughly 1,098 mOsm/kg, which is more than three times the normal osmolality of human blood plasma (around 275 to 295 mOsm/kg). This large osmotic gap is exactly the point: mannitol’s usefulness depends on its ability to pull water out of tissues and into the bloodstream.
Why Mannitol’s Tonicity Matters
Tonicity describes how a solution behaves relative to the fluid inside and around your cells. A hypertonic solution has a higher concentration of dissolved particles than your body’s own fluids. When mannitol enters the bloodstream through an IV, it raises plasma tonicity significantly because it acts as a new solute that your cells and certain barriers in the body cannot absorb. Water naturally moves toward the side with more dissolved particles, so tissues exposed to mannitol-rich blood lose water into the bloodstream.
This is why mannitol is classified as an osmotic agent. It doesn’t work through a chemical reaction or by binding to a receptor. It works through simple physics: the concentration difference between the blood (now loaded with mannitol) and surrounding tissues creates a gradient that forces water to move.
How It Works in the Brain
The most well-known use of mannitol takes advantage of the blood-brain barrier, a tightly sealed layer of cells that prevents most substances from passing between the bloodstream and brain tissue. Under normal conditions, brain tissue is actually slightly more concentrated than blood, with an osmotic gradient of about 3 mOsm/kg favoring the brain side. Mannitol flips that gradient. Because mannitol molecules are too large to cross the intact blood-brain barrier, they stay in the blood and dramatically raise its osmolality. Water then flows out of swollen brain tissue and into blood vessels, reducing brain volume and lowering pressure inside the skull.
The same principle applies to the eyes. Mannitol draws water out of the vitreous humor (the gel-like fluid inside the eye) and into the bloodstream, which lowers pressure within the eye. This can be useful in acute situations where eye pressure spikes dangerously.
How Mannitol Compares to Hypertonic Saline
Mannitol isn’t the only hypertonic option for reducing brain swelling. Concentrated salt solutions, particularly 3% saline (osmolality around 1,054 mOsm/kg), serve a similar purpose. The two are remarkably close in osmolality, and a meta-analysis of 544 patients with traumatic brain injuries found that both reduce elevated intracranial pressure effectively and kick in at roughly the same speed.
The differences show up in the details. Mannitol was slightly more effective at the initial pressure drop itself, while 3% saline maintained its pressure-lowering effect for a significantly longer duration. Hypertonic saline also performed better at maintaining blood flow to the brain after treatment. Mannitol, on the other hand, has a built-in exit strategy: it travels with the water it mobilizes straight to the kidneys and gets flushed out in urine, acting as a powerful diuretic in the process. Hypertonic saline stays in the body longer and doesn’t promote the same level of fluid removal.
What Happens After Mannitol Enters the Body
Once infused, mannitol is not metabolized. Your body treats it as a foreign solute that needs to be filtered out. The kidneys excrete it rapidly, and it carries a large volume of water along with it. This diuretic effect is one reason mannitol requires careful monitoring. As the kidneys flush out water, electrolyte levels can shift, and significant fluid loss can lead to dehydration if not managed.
There is also a ceiling for safe use. Clinical guidelines generally aim to keep blood osmolality between 300 and 320 mOsm/kg during mannitol therapy. When osmolality climbs above 320 mOsm/kg, the risk of kidney injury rises substantially. Repeated or prolonged use can overwhelm the kidneys’ ability to handle the osmotic load.
Practical Details Worth Knowing
Because mannitol is so concentrated, it has a tendency to form crystals, especially when stored at cooler temperatures. If crystals appear in the solution, the container needs to be warmed to about 80°C (176°F) and shaken until the crystals dissolve, then cooled back to body temperature before use. For the most concentrated formulation (25%), an in-line filter is required during administration to catch any undissolved particles. These aren’t minor technicalities. Infusing crystallized mannitol could block small blood vessels, so proper preparation is a standard safety step.
Mannitol is poorly absorbed when taken by mouth, which is why it is given intravenously for conditions involving brain or eye pressure. Oral mannitol stays in the gut and draws water into the intestines rather than affecting the bloodstream, a completely different clinical use.